Treatment of Abdominal Distension by Biofeedback - a Randomized Controlled Trial
NCT01205100 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2016-07-27
Summary
Background: Abdominal bloating is a frequent and bothersome complaint in patients with functional gut disorders without satisfactory treatment to date. Recent data from our laboratory indicate that abdominal distention in these patients is produced by abdomino-phrenic dyssynergia: diaphragmatic contraction associated with abdominal wall relaxation (particularly the internal oblique). In analogy to other clinical situations (e.g. functional outlet obstruction, rumination or aerophagia) behavioral treatment by means of biofeedback might be equally effective in these patients. The investigators hypothesized that abdomino-phrenic coordination and abdominal distention can be controlled by biofeedback techniques.
Aim: to prove the efficacy of behavioural treatment using biofeedback techniques for abdominal distension.
Randomization: Patients will be randomized into biofeedback and placebo groups.
Intervention. Biofeedback: patients will be taught to control abdominothoracic muscular activity by bio-feedback using online electromyography information. Placebo: patients will be given a pill containing placebo medication. Interventions will be delivered in 3 sessions (20 min each) over 10-day period
. Measurements: Sensation of abdominal distension will be assessed by means of graphic rating scales graded from 0 (no perception) to 6 (very intense sensation). The activity of the abdomino-thoracic muscles will be recorded. Abdominal distension will be measured by a metric tape fixed to a non-stretch belt placed over the umbilicus.
Outcomes: Primary outcome: Change in sensation of abdominal sensation. Secondary outcomes: a) changes in thoraco-abdominal activity of the muscular walls; activity of thoraco-abdominal muscles (intercostals, diaphragm, external oblique, internal oblique, upper rectus, lower rectus) will be measured by electromyography; b) changes in girth; abdominal girth will be measured using a nonstretch belt (48mm wide) that is placed over the umbilicus. The overlapping ends of the belt will be adjusted carefully with two elastic bands to adapt constantly to the abdominal wall.
Conditions
- Irritable Bowel Syndrome
- Dyspepsia
Interventions
- BEHAVIORAL
-
Bio-feedback
By providing on-line electromyography information of muscle activity, patients will be able to control and actively correct their muscle activity during the 15 min treatment session. Each patients will attend 3 treatment sessions.
- DRUG
Sponsors & Collaborators
-
Hospital Universitari Vall d'Hebron Research Institute
lead OTHER
Principal Investigators
-
Fernando Azpiroz, M.D. · University Hospital Vall d'Hebron
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2016-01-31
- Completion
- 2016-06-30
Countries
- Spain
Study Locations
More Related Trials
-
A Heart Rate Variability (HRV) Biofeedback Training in Functional Gastrointestinal Disorders (FGID)
NCT06687057 ·Status: RECRUITING ·Phase: NA
-
Fecobionics in Biofeedback Therapy in Dyssynergia Patients
NCT05807321 ·Status: RECRUITING ·Phase: NA
-
Evaluating and Treating Potential Research Participants With Digestive Disorders
NCT01736280 ·Status: TERMINATED ·Phase: NA
-
Effect of Diet on Intestinal Gas Production and Evacuation in Healthy Subjects and Flatulent Patients
NCT01291446 ·Status: COMPLETED ·Phase: NA
-
Study of Clinical Features and Efficacy of Small Intestinal Bacterial Overgrowth in Patients With Abdominal Distension
NCT06518850 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Endogenous Inhibitory Modulation During Gastric and Somatic Stimulation
NCT00693407 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation in Irritable Bowel Syndrome With Bloating
NCT02299973 ·Status: COMPLETED ·Phase: NA
-
"Functional Bowel Disorder. Investigation in General Practice"
NCT01153295 ·Status: COMPLETED ·Phase: NA
-
Brain-Gut Interactions in Overweight and Normal Weight Patients With Chronic Abdominal Pain
NCT00824941 ·Status: TERMINATED
-
Marine Protein Hydrolysate as Dietary Supplement in Irritable Bowel Syndrome
NCT03801057 ·Status: COMPLETED ·Phase: NA
-
Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome
NCT00738920 ·Status: COMPLETED ·Phase: NA
-
Vagal Nerve Stimulation in Irritable Bowel Syndrome
NCT06090110 ·Status: RECRUITING ·Phase: NA
-
Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide
NCT00584298 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Functional Bowel Disorders
NCT00006157 ·Status: COMPLETED ·Phase: PHASE3
-
ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study.
NCT03252743 ·Status: COMPLETED ·Phase: NA
-
Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas
NCT04656730 ·Status: COMPLETED ·Phase: PHASE4
-
Prebiotic Properties of Phenolic Compounds
NCT05197218 ·Status: COMPLETED ·Phase: NA
-
Functional Digestive Disorders Observatory
NCT04918329 ·Status: RECRUITING
-
Development of Limited Contact CBT Treatment for IBS
NCT00248586 ·Status: COMPLETED ·Phase: NA
-
SIBO, Immune Activation, and FGIDs in Children
NCT02872961 ·Status: COMPLETED
-
Irritable Bowel Syndrome Hypnotherapy
NCT01248013 ·Status: COMPLETED ·Phase: NA
-
Response of Irritable Bowel Syndrome to Abdominal Fat Reduction
NCT05879692 ·Status: UNKNOWN ·Phase: NA
-
Internet-delivered Exposure-based Cognitive Behavior Therapy for Irritable Bowel Syndrome - a Cohort Effectiveness Study
NCT05328245 ·Status: COMPLETED
-
The Association of Clinical Symptom Clusters With Underlying Mechanisms in Functional Gastrointestinal Disorders
NCT04331223 ·Status: COMPLETED
-
Cognitive Behavior Therapy (CBT) for Children With Functional Gastrointestinal Disorders
NCT02113605 ·Status: COMPLETED ·Phase: NA